Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies

被引:2
|
作者
Wang, Kang [1 ]
Wang, Yun [2 ]
Yin, Kai [3 ]
机构
[1] Jiangsu Univ, Affiliated Hosp, Dept Gen Surg, Jiefang Rd 438, Zhenjiang 212000, Jiangsu, Peoples R China
[2] First Peoples Hosp Changzhou, Dept Dermatol, Juqian St, Changzhou 213003, Jiangsu, Peoples R China
[3] Jiangsu Univ, Affiliated Hosp, Inst Digest Dis, Dept Gen Surg, Jiefang Rd 438, Zhenjiang 212000, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
MDSC; Colitis-associated colorectal cancer; CRC; Targeting strategies; PHASE-II TRIAL; SUPPRESSOR-CELLS; OPEN-LABEL; MYELOID CELLS; CHEMOTHERAPY; PROMOTES; DIFFERENTIATION; MULTICENTER; BEVACIZUMAB; EFFICACY;
D O I
10.1007/s00432-024-05755-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colitis-associated colorectal cancer has been a hot topic in public health issues worldwide. Numerous studies have demonstrated the significance of myeloid-derived suppressor cells (MDSCs) in the progression of this ailment, but the specific mechanism of their role in the transformation of inflammation to cancer is unclear, and potential therapies targeting MDSC are also unclear. This paper outlines the possible involvement of MDSC to the development of colitis-associated colorectal cancer. It also explores the immune and other relevant roles played by MDSC, and collates relevant targeted therapies against MDSC. In addition, current targeted therapies for colorectal cancer are analyzed and summarized.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] The Role Played by PepT1 in Colitis-Associated Cancer
    Ingersoll, Sarah
    Ayyadurai, Saravanan
    Charania, Moiz A.
    Laroui, Hamed
    Yan, Yutao
    Xiao, Bo
    Merlin, Didier
    GASTROENTEROLOGY, 2012, 142 (05) : S637 - S637
  • [2] G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers
    Li, Wenbin
    Zhang, Xinghua
    Chen, Yongkang
    Xie, Yibin
    Liu, Jiancheng
    Feng, Qiang
    Wang, Yi
    Yuan, Wei
    Ma, Jie
    PROTEIN & CELL, 2016, 7 (02) : 130 - 140
  • [3] The role of autophagy in colitis-associated colorectal cancer
    Yuhui Wu
    Junlin Yao
    Jiansheng Xie
    Zhen Liu
    Yubin Zhou
    Hongming Pan
    Weidong Han
    Signal Transduction and Targeted Therapy, 3
  • [4] THE ROLE OF CYCLOOXYGENASE IN COLITIS-ASSOCIATED COLORECTAL CANCER
    Good, Hayley
    Shin, Alice E.
    Zhang, Liyue
    Meriwether, David
    Reddy, Srinivasa
    Wang, Timothy C.
    Fazio, Elena N.
    Asfaha, Samuel
    GASTROENTEROLOGY, 2019, 156 (06) : S836 - S836
  • [5] The role of autophagy in colitis-associated colorectal cancer
    Wu, Yuhui
    Yao, Junlin
    Xie, Jiansheng
    Liu, Zhen
    Zhou, Yubin
    Pan, Hongming
    Han, Weidong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2018, 3
  • [6] The Role of Dyslipidemia in Colitis-Associated Colorectal Cancer
    Chen, Ke
    Guo, Jianrong
    Zhang, Tao
    Gu, Jian
    Li, Huili
    Wang, Jiliang
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [7] The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer
    Bocchetti, Marco
    Ferraro, Maria Grazia
    Ricciardiello, Filippo
    Ottaiano, Alessandro
    Luce, Amalia
    Cossu, Alessia Maria
    Scrima, Marianna
    Leung, Wing-Yan
    Abate, Marianna
    Stiuso, Paola
    Caraglia, Michele
    Zappavigna, Silvia
    Yau, Tung On
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [8] The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer
    Luo, Chengxin
    Zhang, Hu
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [9] Ulcerative colitis-associated colorectal cancer
    Yashiro, Masakazu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (44) : 16389 - 16397
  • [10] Ulcerative colitis-associated colorectal cancer
    Masakazu Yashiro
    World Journal of Gastroenterology, 2014, (44) : 16389 - 16397